LAB.FARMACEUTICOS ROVI

07/08 CET
Closure
ISIN ES0157261019
Last:
27.5000
Dif:
-0.6000
(-2.14 %)
Volume:
47,988
1 Year Statistical Data
Data
Listed Days 255
IBEX Correlation (%) 0.76
Volatility [Y] 31.17
Alpha Ratio 0.14
Beta Ratio 0.17
Standard Deviation 1.63
Variance 2.66
Consolidated
2020-2 2019-4 Var.
Net Sales (MM€) 191.129 381.313 -49.88
P.B.T (MM€) 32.841 41.880 -21.59
Net Profit (MM€) 29.593 39.273 -24.65
Equity (MM€) 352.247 322.389 9.26
Reserves (MM€) 0.673 0.673 0.00
Amortization (MM€) -9.541 -18.216 -47.65
Net Profit/Sales (%) 15.483 10.299 50.29
Sales per share (€) N.A. N.A. N,A,
C.Increase
Thursday
01
/Nov
2018
Type of capital increase: Con Prima
Percentage of the new securities that are issued: 99
Percentage of the old securities:
Price per share: 14.5
Unit nominal of the capital increase:
Rights trading: N
Nominal amount of the capital increase: 33,103
Unit price to be paid in the capital increase: 15
IPO date: 01/11/2018
Capital increase starting date: 01/11/2018
capital increase ending date: 01/11/2018
Economic rights: //
Capital increase in the year: 1
Tuesday
09
/Oct
2018
Type of capital increase: Con Prima
Percentage of the new securities that are issued: 11
Percentage of the old securities: 100
Price per share: 14.5
Unit nominal of the capital increase:
Rights trading: N
Nominal amount of the capital increase: 331,034
Unit price to be paid in the capital increase: 15
IPO date: 09/10/2018
Capital increase starting date: 09/10/2018
capital increase ending date: 09/10/2018
Economic rights: //
Capital increase in the year: 1